 BOSTON, April 06, 2022 GLOBE NEWSWIRE -- Inozyme Pharma, Inc. Nasdaq: INZY, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the companys co-founder, president, and chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13th at 8:45 AM ET. 